Low-Calorie Diet Linked to Improved Chemo Response in Leukemia Low-Calorie Diet Linked to Improved Chemo Response in Leukemia
A low-sugar/low-carb diet and exercise regimen was associated with an improved response to chemotherapy in a pilot study in children and adolescents with leukemia.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

What are the risk factors for experiencing side effects from childhood cancer treatments?
(Wiley) Steroids are essential for treating children with acute lymphoblastic leukemia, a type of cancer of the blood and bone marrow, but they can cause severe side effects such as psychological reactions and sleep problems. An analysis published in Psycho-Oncology of all relevant studies published to date indicates that there's insufficient high-quality research investigating the risk factors for these side effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 7, 2021 Category: International Medicine & Public Health Source Type: news

She ’ s Beating Leukemia With a Healthy Change to Her Diet
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 6, 2021 Category: Cancer & Oncology Tags: Oncology, Pediatrics, Nutrition, News, Source Type: news

She's Beating Leukemia With a Healthy Change to Her Diet
TUESDAY, April 6, 2021 -- Angie Gaytan never cared much for beets, but beets sure do love her -- doctors say that veggie shakes, fruits, beet juice and other healthy foods likely helped the 16-year-old defeat her life-threatening leukemia. Such a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 6, 2021 Category: General Medicine Source Type: news

She's Beating Leukemia With a Healthy Change to Her Diet
Title: She's Beating Leukemia With a Healthy Change to Her DietCategory: Health NewsCreated: 4/6/2021 12:00:00 AMLast Editorial Review: 4/6/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 6, 2021 Category: Cancer & Oncology Source Type: news

Study finds risk of leukemia higher than expected in children with Down syndrome
(University of California - Davis Health) The risk of childhood leukemia among kids with Down syndrome is higher than predicted, according to a new study led by UC Davis and UC San Francisco researchers. Early diagnosis of leukemia remains critical. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2021 Category: International Medicine & Public Health Source Type: news

Adding in Stem Cell Therapy Helps Beat a Common Childhood Leukemia
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 2, 2021 Category: Cancer & Oncology Tags: Oncology, Pediatrics, Pharmacy, Research, News, Source Type: news

Combo Therapy Helps Beat a Common Childhood Leukemia
Combining stem cell transplants with cutting-edge immunotherapy prevents leukemia relapses in young people and improves their chances of survival, new research suggests. (Source: WebMD Health)
Source: WebMD Health - April 2, 2021 Category: Consumer Health News Source Type: news

Adding in Stem Cell Therapy Helps Beat a Common Childhood Leukemia
FRIDAY, April 2, 2021 -- Combining stem cell transplants with cutting-edge immunotherapy prevents leukemia relapses in young people and improves their chances of survival, new research suggests. Acute lymphoblastic leukemia is the most common... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 2, 2021 Category: General Medicine Source Type: news

Adding in Stem Cell Therapy Helps Beat a Common Childhood Leukemia
Title: Adding in Stem Cell Therapy Helps Beat a Common Childhood LeukemiaCategory: Health NewsCreated: 4/2/2021 12:00:00 AMLast Editorial Review: 4/2/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 2, 2021 Category: Cancer & Oncology Source Type: news

Low-calorie diet and mild exercise improve survival for young people with leukemia
In some cancers, including leukemia in children and adolescents, obesity can negatively affect survival outcomes. Obese young people with leukemia are 50% more likely to relapse after treatment than their lean counterparts.Now,a study led by researchers at UCLA and Children’s Hospital Los Angeles has shown that a combination of modest dietary changes and exercise can dramatically improve survival outcomes for those with acute lymphoblastic leukemia, the most common childhood cancer.The researchers found that patients who reduced their calorie intake by 10% or more and adopted a moderate exercise program imm...
Source: UCLA Newsroom: Health Sciences - April 1, 2021 Category: Universities & Medical Training Source Type: news

Diet and exercise may increase efficacy of chemotherapy for children with cancer
(American Society of Hematology) New research published today in the journal Blood Advances is the first to show that restricting calories, reducing fat and sugar intake, and increasing physical activity may boost the effectiveness of chemotherapy for older children and adolescents with leukemia. This intervention, which improved chemotherapy outcomes for children being treated at two institutions, will be further studied through a national trial later this year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Low-calorie diet and mild exercise improve survival for young people with leukemia
(University of California - Los Angeles Health Sciences) A study led by researchers at UCLA and CHLA has shown that a combination of modest dietary changes and exercise can dramatically improve survival outcomes for those with acute lymphoblastic leukemia, the most common childhood cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Stem cell transplants prevent relapses of most common childhood cancer
(University of Virginia Health System) Children and young adults who receive CAR T-cell therapy for the most common childhood cancer - acute lymphoblastic leukemia - suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Diet + exercise + chemo = increased survival in youth with leukemia
(Children's Hospital Los Angeles) Study conducted at Children's Hospital Los Angeles shows that diet and exercise led to reduced risk of remaining cancer cells after one month of chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Crnic Institute discovery may explain high risk of leukemia in children with Down syndrome
(University of Colorado Anschutz Medical Campus) Children with Down syndrome are 20-times more likely to develop acute lymphocytic leukemia (ALL) and 150-times more likely to develop acute myeloid leukemia (AML) compared to their typical peers. According to a new study by researchers at the Linda Crnic Institute for Down Syndrome, the reason could be that children with Down syndrome are more likely to present with clonal hematopoiesis (CH), a process in which a blood stem cell acquires a genetic mutation that promotes replication. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 31, 2021 Category: International Medicine & Public Health Source Type: news

Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
DUBLIN, March 30, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 30, 2021 Category: Drugs & Pharmacology Source Type: news

EU Panel Endorses Duvelisib for CLL and Follicular Lymphoma EU Panel Endorses Duvelisib for CLL and Follicular Lymphoma
The panel recommends EU approval for duvelisib (Copiktra) for certain patients with chronic lymphocytic leukemia (CLL) or follicular lymphoma.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Getting a Prescription to Die Remains Tricky Even As Aid-in-Dying Bills Gain Momentum Across the U.S.
Linda Heim knew her dad didn’t plan to wait for the cancer to kill him. For decades, he’d lived in Montana, which they’d thought was one of the few places where terminally ill people could get a prescription to end their life. After two years of being sick, Heim’s dad got the diagnosis in 2019: stage 4 kidney cancer. His physician offered treatments that might extend his life by months. Instead, the 81-year-old asked the doctor for help dying. Heim said her parents left the appointment in their hometown of Billings with two takeaways: The legality of medically assisted death was questionable in Mont...
Source: TIME: Health - March 29, 2021 Category: Consumer Health News Authors: Katheryn Houghton / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news

TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in Combination with Ukoniq (umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the completion of the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) requesting approval... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 29, 2021 Category: Drugs & Pharmacology Source Type: news

Consumer Health: Treating acute lymphocytic leukemia
Acute lymphocytic leukemia is a cancer of the blood and bone marrow. It's the most common type of cancer in children, and treatment results in a good chance for a cure. Acute lymphocytic leukemia also can occur in adults, though the chance of a cure is reduced greatly. Signs and symptoms of acute lymphocytic leukemia [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 29, 2021 Category: Databases & Libraries Source Type: news

Risk Factors Predict Graft Failure in Pediatric Acute Leukemia Patients Risk Factors Predict Graft Failure in Pediatric Acute Leukemia Patients
Researchers have developed a predictive score for the risk of graft failure in patients with acute leukemia who undergo allogeneic hematopoietic stem cell transplantation with ex vivo T-cell depletion.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Some hand sanitizers made amid COVID pandemic have high levels of cancer-causing chemical benzene
An analysis from online pharmacy Valisure found that of 168 brands, 44 batches, or 17%, had detectable levels of benzene, a carcinogen linked to certain blood cancers such as leukemia (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2021 Category: Consumer Health News Source Type: news

Virginia Commonwealth University Scientists Combine dPCR and High-Speed Microscopic Imaging to Reduce Cost of Diagnosing Cancers
VCU scientists used the technique to measure mutations associated with acute myeloid leukemia, potentially offering an attractive alternative to DNA sequencing More accurate but less-costly cancer diagnostics are the Holy Grail of cancer research. Now, research scientists at Virginia Commonwealth University (VCU) say they have developed a clinical laboratory diagnostic technique that could be far […] The post Virginia Commonwealth University Scientists Combine dPCR and High-Speed Microscopic Imaging to Reduce Cost of Diagnosing Cancers appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - March 24, 2021 Category: Laboratory Medicine Authors: Jude Tags: Digital Pathology Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations ACS Alden Chesney MD ame Source Type: news

Decades of radiation-based scientific theory disproven by Ben-Gurion University US-based study
(American Associates, Ben-Gurion University of the Negev) According to the study, lower levels of several types of cancers were found when the radiation levels were on the higher end of the spectrum rather than on the lower end. Among both men and women, there was a significant decrease in lung, pancreatic, colon and rectal cancers. Among men, there were additional decreases in brain and bladder cancers. There was no decrease in cervix, breast or prostate cancers or leukemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 24, 2021 Category: International Medicine & Public Health Source Type: news

Oncotarget: Hispanic Chronic myelomonocytic leukemia patients
(Impact Journals LLC) This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1 (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 22, 2021 Category: International Medicine & Public Health Source Type: news

Drug Trial Snapshot: DAURISMO
DAURISMO is used to treat adults with newly-diagnosed acute myeloid leukemia (AML). It is to be used in patients who•are 75 years of age or older, or•have other medical conditions that prevent the use of standard chemotherapy. AML is a rapidly progressing cancer that forms in the bone marrow and (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 18, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

A leap forward in research on CAR T cell therapy
(University of Helsinki) A study recently published in the journal Science looked into how CAR T immunotherapy could be used to treat solid tumours in addition to leukaemias. The programming of CAR T cells opens avenues for applying cell therapies to, for example, breast cancer or ovarian cancer in the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 18, 2021 Category: Cancer & Oncology Source Type: news

Brazilian plant shows promising anti-cancer effects against skin cancer and leukemia
(Natural News) One of the biggest issues for cancer patients who have tried modern therapies is that these treatments cause plenty of unwanted side effects. Another challenge that has emerged recently is the occurrence of multi-drug resistance (MDR). MDR can be defined as the ability of cancer cells to survive against a wide variety of anti-cancer... (Source: NaturalNews.com)
Source: NaturalNews.com - March 17, 2021 Category: Consumer Health News Source Type: news

Virus Variants Likely Evolved Inside People With Weak Immune Systems
Growing evidence suggests that people with cancer and other conditions that challenge their immune systems may be incubators of mutant viruses. (Source: NYT Health)
Source: NYT Health - March 15, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Coronavirus (2019-nCoV) Immune System Cancer Antibodies Leukemia your-feed-science Source Type: news

New BTK Inhibitor Pirtobrutinib Shows Promise in CLL New BTK Inhibitor Pirtobrutinib Shows Promise in CLL
The drug yielded promising outcomes in patients with chronic lymphocytic leukemia who discontinued BTK inhibitor treatment because of resistance or intolerance, according to results of the BRUIN trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

‘ It ’s a relief, a light at the end of the tunnel ’ – young women and the vaccine
COVID-19 vaccinations are being rolled out at record speed across the UK and UNISON members have been among some of the first people to receive them. National statistics show that young women are a particularly vaccine-hesitant group in society, with a recent survey finding that one in four women aged 18-34 would not take it. Le’Asha Gabriel-Richards is a 26 year old critical care nurse in Manchester. Le’Asha was concerned at first, but has now had both doses of the vaccine: “In the first round of vaccinations, I was a little bit wary. But I did some research and spoke to my other friends who are nurses f...
Source: UNISON Health care news - March 12, 2021 Category: UK Health Authors: Janey Starling Tags: Article Covid vaccine Covid-19 young members Source Type: news

Gene Therapy for Sickle Cell Did Not Cause Patient's Leukemia
THURSDAY, March 11, 2021 -- There is no evidence that a promising gene therapy for sickle cell disease triggered leukemia in a patient, according to the company testing the experimental treatment. Bluebird Bio announced a few weeks ago that a sickle... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Whole-Genome Sequencing Is Accurate for Myeloid Cancers
WEDNESDAY, March 10, 2021 -- A streamlined whole-genome sequencing approach can provide rapid and accurate genomic profiling for acute myeloid leukemia (AML) or myelodysplastic syndromes, according to a study published in the March 11 issue of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Sickle Cell Treatment Not Linked to Cancer, Researchers Say
Trials of experimental gene therapy for sickle cell disease were halted when patients developed worrying illnesses. (Source: NYT Health)
Source: NYT Health - March 10, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Genetics and Heredity Leukemia Clinical Trials DNA (Deoxyribonucleic Acid) Sickle Cell Anemia Bluebird Bio Inc Boston Children ' s Hospital Gene Therapy Source Type: news

Engineered safety switch curbs severe side effects of CAR-T immunotherapy
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that an experimental safety switch incorporated as part of a chimeric antigen receptor-modified T cell therapy (CAR-T) was effective in reducing the severity of a neurotoxic side effect that occurred in a patient treated with CAR-T therapy for an aggressive form of leukemia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2021 Category: Cancer & Oncology Source Type: news

Benefit of Blinatumomab in Kids With Relapsed B-Cell Lymphoma Benefit of Blinatumomab in Kids With Relapsed B-Cell Lymphoma
Two randomized trials show a clear benefit of blinatumomab in combination with conventional chemotherapy in children with high-risk relapsed B-cell acute lymphoblastic leukemia.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 4, 2021 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news

Single cell sequencing opens new avenues for eradicating leukemia at its source
(Center for Genomic Regulation) Cancer stem cells that elude conventional treatments like chemotherapy drive long-term cancer growth and relapse. These cells are difficult to isolate and study because of their low abundance and similarity to other stem cells. Researchers have created a new method that can distinguish cancer stem cells, mature cancer cells and otherwise healthy stem cells based on their genetics and gene expression. The findings open new avenues for cancer research personalised medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 1, 2021 Category: International Medicine & Public Health Source Type: news

Researchers Halt Trials of Promising Sickle Cell Treatment
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible. (Source: NYT Health)
Source: NYT Health - February 23, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Genetic Engineering Leukemia Bluebird Bio Inc Bone Marrow Clinical Trials DNA (Deoxyribonucleic Acid) Drugs (Pharmaceuticals) National Heart, Lung and Blood Institute Busulfan Black People Source Type: news

Researchers Halt Trial of Promising Sickle Cell Treatment
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible. (Source: NYT Health)
Source: NYT Health - February 22, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Leukemia Bone Marrow Genetic Engineering Clinical Trials Bluebird Bio Inc Williams, David II DNA (Deoxyribonucleic Acid) National Heart, Lung and Blood Institute Busulfan Drugs (Pharmaceuticals) Source Type: news

Genetic Mutations May Add to Racial Disparity in Child B-ALL
FRIDAY, Feb. 19, 2021 -- Hispanic/Latino (H/L) children with B-cell acute lymphoblastic leukemia (B-ALL) have an increased incidence of IKZF1 deletion and IGH-CRLF2 translocation, according to a letter to the editor published online Feb. 2 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 19, 2021 Category: Pharmaceuticals Source Type: news

What Are the Stages of Chronic Lymphocytic Leukemia?
Title: What Are the Stages of Chronic Lymphocytic Leukemia?Category: Diseases and ConditionsCreated: 2/16/2021 12:00:00 AMLast Editorial Review: 2/16/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 16, 2021 Category: Cancer & Oncology Source Type: news

Cancer research: Targeted elimination of leukemic stem cells
(Inselspital, Bern University Hospital) Cancer research in Bern has discovered a further mechanism to combat leukemia: a research team at Inselspital, Bern University Hospital and the University of Bern has succeeded in identifying an important signaling pathway for regulating leukemic stem cells. With this discovery, the researchers are expanding the arsenal of potentially highly effective drugs against leukemia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news

Researchers take early step toward leukemia drug therapy
(McMaster University) The team has discovered that for acute myeloid leukemia (AML) patients, there is a dopamine receptor pathway that becomes abnormally activated in the cancer stem cells. This inspired the clinical investigation of a dopamine receptor-inhibiting drug thioridazine as a new therapy for patients, and their focus on adult AML has revealed encouraging results. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news

New classification of leukemia subtypes reveals potential of existing drugs
(University Health Network) Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present in many patients with Acute Myeloid Leukemia (AML) - called NPM1 - that could help predict survival and improve treatment response for patients whose leukemic cells bear the mutation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2021 Category: International Medicine & Public Health Source Type: news

Sinai team builds first model acute myeloid leukemia progression using CRISPR
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A research team led by the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) has built the first cellular model to depict the evolution of acute myeloid leukemia (AML), from its early to late stages. By using gene editing technologies to alter genes that make cells malignant, the team was able to identify potential therapeutic targets for early disease stages. The study was reported in the journal Cell Stem Cell in February. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2021 Category: Cancer & Oncology Source Type: news

Legendary Oncologist Emil J. Freireich, MD, Dies at 93 Legendary Oncologist Emil J. Freireich, MD, Dies at 93
Recognized as the father of modern leukemia therapy and modern clinical cancer research, Emil Freireich, MD, was a faculty member of the MD Anderson Cancer Center for over 50 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Emil Freireich, Groundbreaking Cancer Researcher, Dies at 93
He helped devise a successful chemotherapy regimen for childhood leukemia, which had long been a death sentence. (Source: NYT Health)
Source: NYT Health - February 7, 2021 Category: Consumer Health News Authors: Richard Sandomir Tags: Frei, Emil III (1924-2013) Deaths (Obituaries) Leukemia National Cancer Institute National Institutes of Health University of Texas M D Anderson Cancer Center Blood Donation Freireich, Emil Source Type: news

Pioneering Cancer Researcher Emil Freireich Dies at 93
The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy. (Source: The Scientist)
Source: The Scientist - February 5, 2021 Category: Science Tags: News & Opinion Source Type: news

TBI Beats Chemoconditioning for ALL Transplants in Children TBI Beats Chemoconditioning for ALL Transplants in Children
Total body irradiation (TBI) plus etoposide remains the conditioning regimen of choice for children undergoing transplant for acute lymphoblastic leukemia (ALL).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news